GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value ($000): $191,481 (100.0% shares, 0.0% debt)

Holdings (36)

— FURIEX PHARMACEUTICALS INC 9.4%

Value ($000) $17,910 Shares 205,858 Est. Cost $43.99 Unrealized —

— HYPERION THERAPEUTICS INC 6.7%

Value ($000) $12,739 Shares 493,751 Est. Cost $26.13 Unrealized —

— PAIN THERAPEUTICS INC 6.6%

Value ($000) $12,580 Shares 2,287,279 Est. Cost $2.72 Unrealized —

— ALIMERA SCIENCES INC 6.2%

Value ($000) $11,835 Shares 1,500,000 Est. Cost $7.89 Unrealized —

— DERMA SCIENCES INC 6.1%

Value ($000) $11,729 Shares 925,000 Est. Cost $12.68 Unrealized —

— OXYGEN BIOTHERAPEUTICS INC 5.8%

Value ($000) $11,100 Shares 2,000,000 Est. Cost $5.55 Unrealized —

NBIX NEUROCRINE BIOSCIENCES INC 5.2%

Value ($000) $9,982 Shares 620,000 Est. Cost $17.10 Unrealized 0.0%

OM2 ORTHOFIX INTL N V 4.2%

Value ($000) $7,990 Shares 265,000 Est. Cost $30.15 Unrealized —

OM2 ORTHOFIX INTL N V 3.9%

Value ($000) $7,538 Shares 250,000 Est. Cost $30.15 Unrealized —

— AMBIT BIOSCIENCES CORP 3.4%

Value ($000) $6,560 Shares 719,261 Est. Cost $15.50 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 3.1%

Value ($000) $5,950 Shares 500,400 Est. Cost $14.05 Unrealized -4.5%

— VOLCANO CORPORATION 3.1%

Value ($000) $5,913 Shares 300,000 Est. Cost $22.13 Unrealized —

— ALCOBRA LTD 2.8%

Value ($000) $5,329 Shares 293,610 Est. Cost $18.02 Unrealized —

VCYT VERACYTE INC 2.8%

Value ($000) $5,315 Shares 310,248 Est. Cost $13.01 Unrealized +22.7%

— SOPHIRIS BIO INC 2.6%

Value ($000) $4,995 Shares 1,500,000 Est. Cost $4.51 Unrealized —

— ANTHERA PHARMACEUTICALS INC 2.4%

Value ($000) $4,587 Shares 1,369,237 Est. Cost $3.35 Unrealized —

— AVEO PHARMACEUTICALS INC 2.2%

Value ($000) $4,285 Shares 2,866,483 Est. Cost $1.83 Unrealized —

— RECRO PHARMA INC 2.2%

Value ($000) $4,246 Shares 580,000 Est. Cost $7.32 Unrealized —

— SUNSHINE HEART INC 2.2%

Value ($000) $4,246 Shares 727,000 Est. Cost $11.58 Unrealized —

— PROTALIX BIOTHERAPEUTICS INC 2.2%

Value ($000) $4,178 Shares 912,155 Est. Cost $4.15 Unrealized —

— CARA THERAPEUTICS INC 1.7%

Value ($000) $3,314 Shares 178,065 Est. Cost $18.61 Unrealized —

— OCERA THERAPEUTICS INC 1.7%

Value ($000) $3,290 Shares 311,821 Est. Cost $12.99 Unrealized —

CYTK CYTOKINETICS INC 1.6%

Value ($000) $2,993 Shares 315,000 Est. Cost $9.04 Unrealized 0.0%

— ONCOTHYREON INC 1.5%

Value ($000) $2,965 Shares 991,800 Est. Cost $2.99 Unrealized —

— NANOSPHERE INC 1.4%

Value ($000) $2,753 Shares 1,280,309 Est. Cost $2.00 Unrealized —

— DIPEXIUM PHARMACEUTICALS INC 1.3%

Value ($000) $2,520 Shares 250,000 Est. Cost $10.08 Unrealized —

— MANNKIND CORP 1.1%

Value ($000) $2,199 Shares 546,900 Est. Cost $4.02 Unrealized —

— MANNKIND CORP 1.1%

Value ($000) $2,119 Shares 527,000 Est. Cost $4.02 Unrealized —

— MEI PHARMA INC 0.9%

Value ($000) $1,755 Shares 157,661 Est. Cost $11.25 Unrealized —

— CHEMOCENTRYX INC 0.9%

Value ($000) $1,656 Shares 249,700 Est. Cost $5.79 Unrealized —

— ONCOGENEX PHARMACEUTICALS IN 0.8%

Value ($000) $1,529 Shares 130,000 Est. Cost — Unrealized —

— KALOBIOS PHARMACEUTICALS INC 0.8%

Value ($000) $1,455 Shares 536,894 Est. Cost $2.71 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.7%

Value ($000) $1,279 Shares 193,567 Est. Cost $6.61 Unrealized —

— PSIVIDA CORP 0.6%

Value ($000) $1,162 Shares 283,313 Est. Cost $3.97 Unrealized —

— STREAMLINE HEALTH SOLUTIONS 0.4%

Value ($000) $763 Shares 151,611 Est. Cost $6.45 Unrealized —

— MOMENTA PHARMACEUTICALS INC 0.4%

Value ($000) $722 Shares 62,000 Est. Cost $11.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	FURIEX PHARMACEUTICALS INC	205,858	$17,910	9.4%	$43.99	—	COM	36106P101
—	HYPERION THERAPEUTICS INC	493,751	$12,739	6.7%	$26.13	—	COM	44915N101
—	PAIN THERAPEUTICS INC	2,287,279	$12,580	6.6%	$2.72	—	COM	69562K100
—	ALIMERA SCIENCES INC	1,500,000	$11,835	6.2%	$7.89	—	COM	016259103
—	DERMA SCIENCES INC	925,000	$11,729	6.1%	$12.68	—	COM PAR $.01	249827502
—	OXYGEN BIOTHERAPEUTICS INC	2,000,000	$11,100	5.8%	$5.55	—	COM PAR $0.0001	69207P308
NBIX	NEUROCRINE BIOSCIENCES INC	620,000	$9,982	5.2%	$17.10	0.0%	COM	64125C109
OM2	ORTHOFIX INTL N V	265,000	$7,990	4.2%	$30.15	—	Put	N6748L102
OM2	ORTHOFIX INTL N V	250,000	$7,538	3.9%	$30.15	—	COM	N6748L102
—	AMBIT BIOSCIENCES CORP	719,261	$6,560	3.4%	$15.50	—	COM	02318X100
INFIQ	INFINITY PHARMACEUTICALS INC	500,400	$5,950	3.1%	$14.05	-4.5%	COM	45665G303
—	VOLCANO CORPORATION	300,000	$5,913	3.1%	$22.13	—	COM	928645100
—	ALCOBRA LTD	293,610	$5,329	2.8%	$18.02	—	SHS	M2239P109
VCYT	VERACYTE INC	310,248	$5,315	2.8%	$13.01	+22.7%	COM	92337F107
—	SOPHIRIS BIO INC	1,500,000	$4,995	2.6%	$4.51	—	COM NEW	83578Q209
—	ANTHERA PHARMACEUTICALS INC	1,369,237	$4,587	2.4%	$3.35	—	COM NEW	03674U201
—	AVEO PHARMACEUTICALS INC	2,866,483	$4,285	2.2%	$1.83	—	COM	053588109
—	RECRO PHARMA INC	580,000	$4,246	2.2%	$7.32	—	COM	75629F109
—	SUNSHINE HEART INC	727,000	$4,246	2.2%	$11.58	—	COM	86782U106
—	PROTALIX BIOTHERAPEUTICS INC	912,155	$4,178	2.2%	$4.15	—	COM	74365A101
—	CARA THERAPEUTICS INC	178,065	$3,314	1.7%	$18.61	—	COM	140755109
—	OCERA THERAPEUTICS INC	311,821	$3,290	1.7%	$12.99	—	COM	67552A108
CYTK	CYTOKINETICS INC	315,000	$2,993	1.6%	$9.04	0.0%	COM NEW	23282W605
—	ONCOTHYREON INC	991,800	$2,965	1.5%	$2.99	—	COM	682324108
—	NANOSPHERE INC	1,280,309	$2,753	1.4%	$2.00	—	COM	63009F105
—	DIPEXIUM PHARMACEUTICALS INC	250,000	$2,520	1.3%	$10.08	—	COM	25456J104
—	MANNKIND CORP	546,900	$2,199	1.1%	$4.02	—	COM	56400P201
—	MANNKIND CORP	527,000	$2,119	1.1%	$4.02	—	Call	56400P201
—	MEI PHARMA INC	157,661	$1,755	0.9%	$11.25	—	COM NEW	55279B202
—	CHEMOCENTRYX INC	249,700	$1,656	0.9%	$5.79	—	COM	16383L106
—	ONCOGENEX PHARMACEUTICALS IN	130,000	$1,529	0.8%	—	—	Call	68230A106
—	KALOBIOS PHARMACEUTICALS INC	536,894	$1,455	0.8%	$2.71	—	COM	48344T100
—	SUNESIS PHARMACEUTICALS INC	193,567	$1,279	0.7%	$6.61	—	COM NEW	867328601
—	PSIVIDA CORP	283,313	$1,162	0.6%	$3.97	—	COM	74440J101
—	STREAMLINE HEALTH SOLUTIONS	151,611	$763	0.4%	$6.45	—	COM	86323X106
—	MOMENTA PHARMACEUTICALS INC	62,000	$722	0.4%	$11.65	—	COM	60877T100